BIOMET CEMENTING TECHNOLOGIES AB – Trademark Portfolio

Entity Type: 03

BIOMET CEMENTING TECHNOLOGIES AB holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 3 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OPTIVAC. The owner is based in SJOBO.

FORSKAREGATAN 1

SJOBO S-275 37 , SE

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

OPTIPAC
OPTIPAC
Cancelled 2006
OPTIVAC
OPTIVAC
Registered 1997

Trademark Classifications

BIOMET CEMENTING TECHNOLOGIES AB's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does BIOMET CEMENTING TECHNOLOGIES AB have?

BIOMET CEMENTING TECHNOLOGIES AB has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.

What trademark classes does BIOMET CEMENTING TECHNOLOGIES AB file in?

BIOMET CEMENTING TECHNOLOGIES AB files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are BIOMET CEMENTING TECHNOLOGIES AB's most well-known trademarks?

BIOMET CEMENTING TECHNOLOGIES AB's registered trademark portfolio includes well-known marks such as OPTIVAC. These are among 1 currently registered trademark in the portfolio.

What is BIOMET CEMENTING TECHNOLOGIES AB's trademark registration success rate?

BIOMET CEMENTING TECHNOLOGIES AB has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.